- Home
- Publications
- Publication Search
- Publication Details
Title
How I treat NK/T-cell lymphomas
Authors
Keywords
-
Journal
BLOOD
Volume 121, Issue 25, Pages 4997-5005
Publisher
American Society of Hematology
Online
2013-05-08
DOI
10.1182/blood-2013-01-453233
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HACE1 Is a Tumor Suppressor Gene Candidate in Natural Killer Cell Neoplasms
- (2012) Can Küçük et al. AMERICAN JOURNAL OF PATHOLOGY
- Extranodal NK/T-cell Lymphoma, Nasal Type
- (2012) Shaoying Li et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis
- (2012) H. K. Ahn et al. ANNALS OF ONCOLOGY
- SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
- (2012) Y.-L. Kwong et al. BLOOD
- Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases
- (2012) J. A. Laurini et al. BLOOD
- Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy
- (2012) Z.-Y. Wang et al. BLOOD
- First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma
- (2012) Liang Wang et al. CANCER
- Aggressive natural killer cell leukemia: Therapeutic potential of l-asparaginase and allogeneic hematopoietic stem cell transplantation
- (2012) Fumihiro Ishida et al. CANCER SCIENCE
- Practical management of natural killer/T-cell lymphoma
- (2012) Eric Tse et al. CURRENT OPINION IN ONCOLOGY
- Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma
- (2012) Hee Kyung Ahn et al. INVESTIGATIONAL NEW DRUGS
- Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: An Updated Analysis of the Japan Clinical Oncology Group Study JCOG0211
- (2012) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma
- (2012) Ghee Chong Koo et al. Cancer Discovery
- Clinicopathologic and Molecular Features of 122 Brazilian Cases of Nodal and Extranodal NK/T-Cell Lymphoma, Nasal Type, With EBV Subtyping Analysis
- (2011) Gabriela Gualco et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma
- (2011) S.-B. Ng et al. BLOOD
- Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type
- (2011) R. Suzuki et al. BLOOD
- Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses
- (2011) K. Karube et al. BLOOD
- Phase 2 trial of “Sandwich”L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma
- (2011) Ming Jiang et al. CANCER
- Mild Toxicity and Favorable Prognosis of High–Dose and Extended Involved-Field Intensity-Modulated Radiotherapy for Patients With Early-Stage Nasal NK/T-Cell Lymphoma
- (2011) Hua Wang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
- (2011) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type
- (2011) Daisuke Ennishi et al. LEUKEMIA & LYMPHOMA
- PRDM1 is a tumor suppressor gene in natural killer cell malignancies
- (2011) C. Kucuk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
- (2010) A. Jaccard et al. BLOOD
- NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series
- (2010) A. Mansoor et al. BLOOD
- Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation
- (2010) K. Takeuchi et al. BLOOD
- A role for Blimp1 in the transcriptional network controlling natural killer cell maturation
- (2010) A. Kallies et al. BLOOD
- Metabolic Activity Measured by F-18 FDG PET in Natural Killer-Cell Lymphoma Compared to Aggressive B- and T-Cell Lymphomas
- (2010) Winnie K. S. Chan et al. CLINICAL NUCLEAR MEDICINE
- Treatment of localized extranodal NK/T cell lymphoma, nasal type
- (2010) Seok Jin Kim et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Hematopoietic stem cell transplantation in natural killer cell lymphoma and leukemia
- (2010) Yok-Lam Kwong INTERNATIONAL JOURNAL OF HEMATOLOGY
- Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling
- (2010) Siok-Bian Ng et al. JOURNAL OF PATHOLOGY
- Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro
- (2010) J Iqbal et al. LEUKEMIA
- Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type
- (2009) R. Suzuki et al. ANNALS OF ONCOLOGY
- Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type
- (2009) Y. Huang et al. BLOOD
- Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents
- (2009) Z.-Y. Wang et al. BLOOD
- High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies
- (2009) Y-L Kwong BONE MARROW TRANSPLANTATION
- Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
- (2009) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
- (2009) Seok Jin Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009
- (2009) Yok-Lam Kwong et al. LANCET ONCOLOGY
- Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies
- (2008) Pek-Lan Khong et al. ANNALS OF HEMATOLOGY
- Non-nasal natural killer cell lymphoma: not non-nasal after all
- (2008) Eric Tse et al. ANNALS OF HEMATOLOGY
- Autologous Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T Cell Lymphoma: A Multinational, Multicenter, Matched Controlled Study
- (2008) Jeeyun Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started